X4 Pharmaceuticals (XFOR) Exchange Rate Effect (2017 - 2026)
X4 Pharmaceuticals' (XFOR) quarterly Exchange Rate Effect came in at -$5000.0 in Q2 2026, down 103.6% on a YoY basis from $139000.0 in Q2 2025, and up 75.0% quarter-over-quarter from -$20000.0 in Q1 2026.
Powered by 
Analysis
X4 Pharmaceuticals (XFOR) Exchange Rate Effect (2017 - 2026) Analysis & Trends
X4 Pharmaceuticals (XFOR) has reported Exchange Rate Effect for 10 consecutive years, with -$5000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Exchange Rate Effect fell 103.6% year-over-year to -$5000.0; the trailing twelve-month figure through Jun 2026 stood at -$23000.0 (down 117.42% YoY), and the FY2025 full-year result was $213000.0, up 236.54% from the prior year.
- Exchange Rate Effect climbed to -$5000.0 in Q2 2026 per XFOR's latest filing, from -$20000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $363000.0 in Q4 2022 and bottomed at -$244000.0 in Q4 2024.
- Historically, Exchange Rate Effect has averaged $1444.4 across 5 years, with a median of -$5500.0 in 2023.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect sank 605.0% in 2022, then jumped 872.22% in 2025.
- Over 5 years, Exchange Rate Effect stood at $363000.0 in 2022, then plunged by 65.01% to $127000.0 in 2023, then tumbled by 292.13% to -$244000.0 in 2024, then surged by 101.23% to $3000.0 in 2025, then slumped by 266.67% to -$5000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$5000.0, -$20000.0, and $3000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 5.00 Mn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | -7.00 Mn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -37.00 Mn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -18.00 Mn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -4.00 Mn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 11.62 Mn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 19.84 Mn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | -84,000.00 |
| 10 | X4 Pharmaceuticals | 510.43 Mn | 315.33 Mn | 7.19 Mn | -5,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5,000.00 |
| Mar 31, 2026 | -20,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Dec 31, 2024 | -244,000.00 |
| Sep 30, 2024 | 165,000.00 |
| Jun 30, 2024 | -18,000.00 |
| Mar 31, 2024 | -59,000.00 |
| Dec 31, 2023 | 127,000.00 |
| Sep 30, 2023 | -72,000.00 |
| Jun 30, 2023 | -6,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Dec 31, 2022 | 363,000.00 |
| Sep 30, 2022 | -197,000.00 |
| Jun 30, 2022 | -202,000.00 |
| Mar 31, 2022 | -69,000.00 |
| Dec 31, 2021 | -116,000.00 |
| Sep 30, 2021 | -100,000.00 |